recombinant human tissue plasminogen activator (Kerun Biopharmaceutical R & D)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerecombinant human tissue plasminogen activator (Kerun Biopharmaceutical R & D)
Drug Alias Namet-PA (Kerun Biopharmaceutical R & D)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionPlasminogen activators
TargetsPlasminogen
Therapy Area/IndicationsMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMyocardial Infarction

Other Information

ATC CodeN/A
Related LinksN/A